Contribution of anti-Hsp70.1 IgG antibody levels to the diagnostic certainty of clinically suspected ocular toxoplasmosis

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 11, 2010, Pages 5530-5536

  Chumpitazi, Bernabé ^a   Bouillet, Laurence ^b,c   Fricker Hidalgo, Hélène ^a   Lacharme, Tiffany ^d   Romanet, Jean Paul ^d   Massot, Christian ^b   Chiquet, Christophe ^d   Pelloux, Hervé ^a,e  

^a Laboratory of Parasitology and Mycology   (France)

^b Departments of Internal Medicine   (France)

^c INSERM   (France)

^d Polyclinique Comiti   (France)

^e CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HEAT SHOCK PROTEIN 70.1 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; AQUEOUS HUMOR; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TOXOPLASMA GONDII; TOXOPLASMOSIS; UVEITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, PROTOZOAN; AQUEOUS HUMOR; BLOOD DONORS; CASE-CONTROL STUDIES; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TOXOPLASMA; TOXOPLASMOSIS, OCULAR; UVEITIS, POSTERIOR;

EID: 79956060323     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5244     Document Type: Article

References (39)

1. Weiss LM, Dubey JP. Toxoplasmosis: a history of clinical observations. Int J Parasitol. 2009;39:895-901.
2. Holland GN, O'Connor GR, Belfort R Jr, Remington JS. Toxoplasmosis. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. St. Louis MO: Mosby-Year Book; 1996.
3. Dodds EM, Holland GN, Stanford MR, et al. Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am J Ophthalmol. 2008;146:856-865.
4. Smith JR, Cunningham ET Jr. Atypical presentations of ocular toxoplasmosis. Curr Opin Ophthalmol. 2002;13:387-392.
5. Goldmann H, Witmer R. Antikorper im kammerwasser. Ophthalmologica. 1954;127:323-330.
6. Desmonts G. Definitive serological diagnosis of ocular toxoplasmosis. Arch Ophthalmol. 1966;76:839-851.
7. Talabani H, Asseraf M, Yera H, et al. Contributions of immunoblotting, real-time PCR, and the Goldmann-Witmer coefficient to diagnosis of atypical toxoplasmic retinochoroiditis. J Clin Microbiol. 2009;47:2131-2135.
8. Fekkar A, Bodaghi B, Touafek F, et al. Comparison of immunoblotting, calculation of the Goldmann-Witmer coefficient and real-time PCR using aqueous humor samples for diagnosis of ocular toxoplasmosis. J Clin Microbiol. 2008;46:1965-1967.
9. Fardeau C, Romand S, Rao N, et al. Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol. 2002;134:196-203.
10. Garweg JG. Determinants of immunodiagnostic success in human ocular toxoplasmosis. Parasite Immunol. 2005;27:61-68.
11. Stein-Streilein J. Immune regulation and the eye. Trends Immunol. 2008;29:548-554.
12. Norose K, Aosai F, Mun HS, Yano A. Effects of sulfamethoxazole on murine ocular toxoplasmosis in interferon-gamma knockout mice. Invest Ophthalmol Vis Sci. 2006;47:265-271.
13. Wallon M, Kodjikian L, Binquet C, et al. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics. 2004;113:1567-1572.
14. Zugel U, Kaufmann SH. Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev. 1999;12:19-39.
15. Asea A, Kraeft SK, Kurt-Jones EA, et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med. 2000;6:435-442.
16. Asea A, Rehli M, Kabingu E, et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem. 2002;277:15028-15034.
17. Ma YF, Zhang Y, Kim K, Weiss LM. Identification and characterisation of a regulatory region in the Toxoplasma gondii hsp70 genomic locus. Int J Parasitol. 2004;34:333-346.
18. Silva NM, Gazzinelli RT, Silva DA, et al. Expression of Toxoplasma gondii-specific heat shock protein 70 during in vivo conversion of bradyzoites to tachyzoites. Infect Immun. 1998;66:3959-3963.
19. Lyons RE, Johnson AM. Heat shock proteins of Toxoplasma gondii. Parasite Immunol. 1995;17:353-359.
20. Fang H, Aosai F, Mun H, et al. Anaphylactic reaction induced by Toxoplasma gondii-derived heat shock protein 70. Int Immunol. 2006; 18:1487-1497.
21. Calderwood SK, Mambula SS, Gray PJ Jr, Theriault JR. Extracellular heat shock proteins in cell signaling. FEBS Lett. 2007;581:3689-3694.
22. Mohamed RM, Aosai F, Chen M, et al. Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes. Vaccine. 2003;21:2852-2861.
23. Chen M, Aosai F, Mun HS, et al. Correlation between the avidity maturation of anti-HSP70 IgG autoantibody and recombination activating gene expressions in peripheral lymphoid tissues of Toxoplasma gondii-infected mice. Microbiol Immunol. 2003;47:217-221.
24. Chen M, Aosai F, Norose K, et al. The role of anti-HSP70 autoantibody- forming V(H)1-J(H)1 B-1 cells in Toxoplasma gondii-infected mice. Int Immunol. 2003;15:39-47.
25. Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology. 2002;109:869-878.
26. Pelloux H, Mouillon M, Romanet JP, et al. Toxoplasmose oculaire: comparaison de deux méthodes biologiques pour l'étude de l'humeur aqueuse. Presse Med. 1991;20:1655-1658.
27. Brenier-Pinchart MP, Morand-Bui V, Fricker-Hidalgo H, et al. Adapting a conventional PCR assay for Toxoplasma gondii detection to real-time quantitative PCR including a competitive internal control. Parasite. 2007;14:149-154.
28. Chumpitazi BF, Bouillet L, Drouet MT, et al. Biological autoimmunity screening in hepatitis C patients by anti-HepG2 lysate and anti-heat shock protein 70.1 autoantibodies. Eur J Clin Microbiol Infect Dis. 2009;28:137-146.
29. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347:975-982.
30. Brocchieri L, Conway de Macario E, Macario AJ. Hsp70 genes in the human genome: conservation and differentiation patterns predict a wide array of overlapping and specialized functions. BMC Evol Biol. 2008;8:19.
31. Mun HS, Aosai F, Yano A. Role of Toxoplasma gondii HSP70 and Toxoplasma gondii HSP30/bag1 in antibody formation and prophylactic immunity in mice experimentally infected with Toxoplasma gondii. Microbiol Immunol. 1999;43:471-479.
32. Correa D, Cañedo-Solares I, Ortiz-Alegría LB, et al. Congenital and acquired toxoplasmosis: diversity and role of antibodies in different compartments of the host. Parasite Immunol. 2007;29:651-660.
33. Streilein JW, Masli S, Takeuchi M, Kezuka T. The eye's view of antigen presentation. Hum Immunol. 2002;63:435-443.
34. Portela RW, Bethony J, Costa MI, et al. A multihousehold study reveals a positive correlation between age, severity of ocular toxoplasmosis, and levels of glycoinositolphospholipid-specific immunoglobulin A. J Infect Dis. 2004;190:175-183.
35. Johnson MW, Greven GM, Jaffe GJ, et al. Atypical, severe toxoplasmic retinochoroiditis in elderly patients. Ophthalmology. 1997; 104:48-57.
36. Labalette P, Delhaes L, Margaron F, et al. Ocular toxoplasmosis after the fifth decade. Am J Ophthalmol. 2002;133:506-515.
37. Maubon D, Ajzenberg D, Brenier-Pinchart MP, et al. What are the respective host and parasite contributions to toxoplasmosis? Trends Parasitol. 2008;24:299-303.
38. Lahmar I, Abou-Bacar A, Abdelrahman T, et al. Cytokine profiles in toxoplasmic and viral uveitis. J Infect Dis. 2009;199:1239-1249.
39. Dobbin CA, Smith NC, Johnson AM. Heat shock protein 70 is a potential virulence factor in murine Toxoplasma infection via immunomodulation of host NF-kappa B and nitric oxide. J Immunol. 2002;169:958-965.